In the next two weeks, we will finish telling the second part of the story of the antivirals against influenza, oseltamivir and zanamivir. We started telling the story in March, and with the 28th post of the series, we show you how the pandemic stockpiling construct and “interpandemic” use of antivirals is based on thin air. What seems is not, despite 4…
Keep reading with a 7-day free trial
Subscribe to Trust the Evidence to keep reading this post and get 7 days of free access to the full post archives.